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Summary 
Ischemia/reperfusion (IR) induced injury results in significant tissue damage in wild-type, but 
not antibody-deficient, Rag-1-/- mice.  However, Rag-1-/- mice sustain intestinal damage after 
administration of wild-type antibodies or naturally occurring, specific anti-phospholipid related 
monoclonal antibodies, suggesting involvement of a lipid antigen.  We hypothesized that IR 
initiates metabolism of cellular lipids, resulting in production of an antigen recognized by anti-
phospholipid antibodies.  At multiple time points after Sham or IR treatment, lipids extracted 
from mouse jejunal sections were analyzed by electrospray ionization triple quadrupole mass 
spectrometry.  Within 15 min of reperfusion, IR induced significantly more 
lysophosphatidylcholine (lysoPC), lysophosphatidylglycerol (lysoPG) and free arachidonic acid 
(AA) production than Sham treatment.  While lysoPC, lysoPG, and free AA levels were similar 
in C57Bl/6 (wild-type) and Rag-1-/- mice, IR led to Cox-2 activation and prostaglandin E2 
(PGE2) production in wild-type, but not in the antibody-deficient, Rag-1
-/- mice.  Administration 
of wild-type antibodies to Rag-1-/- mice restored PGE2 production and intestinal damage.  These 
data indicate that IR-induced intestinal damage requires antibodies for Cox-2 stimulated PGE2 
production but not for production of lysoPC and free AA.   
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1.  Introduction 
Ischemia, a condition in which a lack of oxygen and nutrients results in severe 
inflammation and cellular damage, is a common medical pathology [1, 2].  Ischemic cells 
undergo biological and chemical changes including activation of numerous proteases and lipases 
which induce tissue damage [3].  Subsequent reperfusion to the ischemic region results in far 
greater injury than observed as a result of ischemia alone [1, 2, 4].  The intestines are thought to 
be the organ most sensitive to reperfusion-induced damage [2, 5].  Mesenteric reperfusion 
damage is associated with multiple organ failure, resulting in a mortality rate ranging from 60 – 
80% in humans [5-7].  Very little is understood about prevention and diagnosis of this condition, 
and therapeutic treatments are limited.  Thus, there is strong incentive to understand the 
mechanisms leading to IR injury in the intestine. 
The pathology of intestinal IR involves neutrophil infiltration and complement activation, 
as either neutrophil depletion [8-10] or complement blockade [11-13] attenuates injury.  
Although naturally resistant to mesenteric IR-induced injury, antibody-deficient, Rag-1-/- mice 
sustain significant inflammation and damage following administration of antibodies (Ab) from 
wild-type mice.  Indeed, Ab play a critical role in both neutrophil recruitment and complement 
activation [14, 15].  After administration of two monoclonal Ab, one recognizing phospholipids 
and another recognizing a phospholipid-binding protein, these damage-resistant mice sustain 
inflammation and intestinal injury at levels seen in wild-type mice [14, 15].  These data suggest 
that a newly expressed lipid antigen (neo-antigen) may be important in reperfusion-induced 
damage.  Identification of lipid alterations during IR might suggest therapeutic targets for 
reperfusion-induced damage. 
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Despite advances in “lipidomics”, or mass spectrometry-based lipid analysis, only a few 
studies have applied this technology to investigate intestinal lipid composition.  One study 
utilized electrospray ionization (ESI)-tandem mass spectrometry (MS/MS) to determine the 
relative prevalence of 10 glycerophospholipid classes in normal rat intestine [16].  Another study 
showed that phosphatidylcholine (PC) and lysophosphatidylcholine (lysoPC) were decreased in 
the intestinal mucus of ulcerative colitis patients [17, 18].  Using lipidomics, a recent study found 
that normal mouse duodenum and jejunum contain the highest concentrations of PC and lysoPC 
among the  intestinal segments [18].  Although intestinal lipid changes in the IR model were not 
investigated in previous studies, the data indicate that lipidomics is a useful tool for identification 
of intestinal lipid changes associated with disease.  ESI-MS/MS may provide a means for 
detection of the IR-induced lipid antigen.  In the current study, we test the hypothesis that 
mesenteric IR alters intestinal lipid composition and examine the role of Ab in IR-induced lipid 
changes and subsequent tissue injury.   
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2.  Methods 
2.1 Mice 
C57Bl/6 wild-type mice and Rag-1-/- mice (Jackson Laboratories) were bred and 
maintained at Kansas State University.  Male mice were between 10 and 16 weeks of age when 
used in experiments.  Mice were maintained in a 12 h light/dark cycle with constant access to 
standard rodent chow (Purina Lab Diet 5001) and water and were not fasted prior to 
experimental use.  All procedures were approved by the Institutional Animal Care and Use 
Committee and were in compliance with the Animal Welfare Act. 
2.2 Intestinal Ischemia Reperfusion 
Mice were subjected to IR as described previously [15].  Briefly, mice were anaesthetized 
by an intraperitoneal injection of 8 mg/kg xylazine and 16 mg/kg ketamine.  All subsequent 
manipulations were performed on a heat pad to maintain body temperature.  After performing a 
midline laparotomy, blood flow to the superior mesenteric artery was occluded for 30 min using 
a small vascular clamp.  Following removal of the clamp and suturing the body wall, the 
intestines were reperfused for 15, 30 or 120 min.  Mice were then euthanized and 1-2 cm long 
jejunal sections (~10 cm distal of the gastroduodenal junction) were removed and fixed in 
formalin or frozen in liquid nitrogen.  Sham-treated animals underwent the same surgical 
procedure without occlusion of the superior mesenteric artery.  Additional Rag-1-/- mice received 
an IV injection of 100 μg of purified Ab 15-20 min prior to occlusion of the superior mesenteric 
artery.  All tissues collected were assayed in a blinded manner. 
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2.3 Injury Scoring of Intestinal Villi 
A formalin-fixed, hematoxylin and eosin-stained transverse jejunum section from each 
mouse was scored for intestinal damage based on a six-tiered scale adapted from Chui et al [19].  
Each villus was assigned a score according to the following criteria: 0: intact villus with no 
damage, 1: bulging of the epithelium, 2: Guggenheim’s space, 3: visible breakage of the 
epithelium, 4: exposure of the intact lamina propria, 5: exuding of the lamina propria, and 6: 
blood loss and denuding of the lamina propria.  Scores from 75-150 villi in a 2 cm section were 
averaged to determine the injury score for that mouse. 
2.4 Lipid Extraction 
Frozen 2 cm jejunal samples were homogenized into a fine powder in liquid nitrogen 
using a steel mortar and pestle and extracted as described previously with adaptations [20, 21].  
A portion of the homogenized tissue was retained for bicinchoninic acid (BCA, Pierce) protein 
analysis.  The remaining tissue (80-150 mg) was suspended in 1 ml cold water.  One ml 
chloroform and 3 ml methanol were added and the sample was shaken vigorously.  An additional 
1 ml chloroform and 1 ml water were added and the sample was centrifuged at 4000 rpm for 5 
min at 4ºC.  The lower (organic) layer was removed and 1 ml chloroform added to the aqueous 
layer.  The sample was again centrifuged and the process repeated for a total of three chloroform 
extractions.  The organic layers from each extraction were pooled and the combined extract 
washed with 1 ml water.  The final extract was submitted for mass spectrometry analysis.   
2.5 Mass Spectrometry Analysis 
An automated ESI-MS/MS approach was used and data acquisition and analysis carried 
out at the Kansas Lipidomics Research Center as described previously [22, 23] with 
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modifications.  Solvent was evaporated from the extracts and each sample was dissolved in 1 ml 
of chloroform.  An aliquot of 20 µl of extract in chloroform was analyzed.  Precise amounts of 
internal standards, obtained and quantified as previously described [24], were added to the 
sample to be analyzed in the following quantities (with some small variation in amounts in 
different batches of internal standards): 0.66 nmol di14:0-PC, 0.66 nmol di24:1-PC, 0.66 nmol 
13:0-lysoPC, 0.66 nmol 19:0-lysoPC, 0.36 nmol di14:0-PE, 0.36 nmol di24:1-PE, 0.36 nmol 
14:0-lysoPE, 0.36 nmol 18:0-lysoPE, 0.36 nmol 14:0-lysoPG, 0.36 nmol 18:0-lysoPG, 0.36 nmol 
di14:0-PA, 0.36 nmol di20:0(phytanoyl)-PA, 0.24 nmol di14:0-PS, 0.24 nmol di20:0(phytanoyl)-
PS, 0.20 nmol 16:0-18:0-PI, 0.16 nmol di18:0-PI, and 1 nmol 15:0 fatty acid.  The sample and 
internal standard mixture were combined with solvents, such that the ratio of 
chloroform/methanol/300 mM ammonium acetate in water was 300/665/35, and the final volume 
was 1.2 ml.  These unfractionated lipid extracts were introduced by continuous infusion into the 
ESI source of a triple quadrupole MS/MS (API 4000, Applied Biosystems, Foster City, CA).  
Samples were introduced using an autosampler (LC Mini PAL, CTC Analytics AG, Zwingen, 
Switzerland) fitted with the required injection loop for the acquisition time and presented to the 
ESI needle at 30 l/min.   
Sequential precursor and neutral loss scans of the extracts produce a series of spectra with 
each spectrum revealing a set of lipid species containing a common head group fragment.  Lipid 
species were detected with the following scans: PC, SM, and lysoPC, [M + H]+ ions in positive 
ion mode with Precursor of 184.1 (Pre 184.1); PE and lysoPE, [M + H]+ ions in positive ion 
mode with Neutral Loss of 141.0 (NL 141.0); PI, [M + NH4]
+ in positive ion mode with NL 
277.0; PS, [M + H]+ in positive ion mode with NL 185.0; PA, [M + NH4]
+ in positive ion mode 
with NL 115.0; PG, [M + NH4]
+ in positive ion mode with NL 189.0; lysoPG, [M – H]- in 
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negative mode with Pre 152.9; and free fatty acids (i.e., free arachidonic acid, (AA)), [M - H]- in 
negative mode with single stage MS analysis.  SM was determined from the same mass spectrum 
as PC (precursors of m/z 184 in positive mode) [25, 26] and by comparison with PC internal 
standards using a molar response factor for SM (in comparison with PC) determined 
experimentally to be 0.39.  Acyl,alk(en)yl (“ether-linked”) ePCs and ePEs were determined in 
relation to the same diacyl standards as other PC and PE species, and no response factors were 
applied.  This approach may result in under-representation of ether-linked molecular species 
[27]. The scan speed was 50 or 100 uper sec.  The collision gas pressure was set at 2 (arbitrary 
units).  The collision energies, with nitrogen in the collision cell, were +28 V for PE, +40 V for 
PC (and SM), +25 V for PI, PS, and PA, +24 V for PG, and –57 V for lysoPG.  Declustering 
potentials were +100 V, except for lysoPG, which was –100 V.  Entrance potentials were +15 V 
for PE, +14 V for PC (and SM), PI, PA, PG, and PS, and –10 V for lysoPG.  Exit potentials were 
+11 V for PE, +14 V for PC (and SM), PI, PA, PG, and PS, and –14 V for lysoPG.  The mass 
analyzers were adjusted to a resolution of 0.7 u full width at half height.  For each spectrum, 9 to 
150 continuum scans were averaged in multiple channel analyzer (MCA) mode.  The source 
temperature (heated nebulizer) was 100C, the interface heater was on, +5.5 kV or -4.5 kV were 
applied to the electrospray capillary, the collision gas was “low”, the curtain gas was set at 20 
(arbitrary units), and the two ion source gases were set at 45 (arbitrary units).   
The background of each spectrum was subtracted, the data were smoothed, and peak 
areas integrated using a custom script and Applied Biosystems Analyst software.  The lipids in 
each class were quantified in comparison to the two internal standards of that class.  The first and 
typically every 11th set of mass spectra were acquired on the internal standard mixture only.  
Peaks corresponding to the target lipids in these spectra were identified and molar amounts 
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calculated in comparison to the internal standards on the same lipid class.  To correct for 
chemical or instrumental noise in the samples, the molar amount of each lipid metabolite 
detected in the “internal standards only” spectra was subtracted from the molar amount of each 
metabolite calculated in each set of sample spectra.  The data from each “internal standards only” 
set of spectra were used to correct the data from the following 10 samples.  Finally, the data were 
expressed as mole percent of total lipid analyzed.  Each class of lipid was also normalized to 
intestinal proteins and expressed as nmol lipid class/mg protein.   
Acyl ions (product ions) of PE, PI, and PS species were identified after collision induced 
dissociation of the [M - H]- ions, and acyl ions of PC species were identified following collision 
induced dissociation of the [M + OAc]- ions. 
2.6 Prostaglandin E2 Concentrations 
A freshly excised mid-jejunal section of intestine was used for analysis of prostaglandin 
E2 (PGE2) as described previously [4, 12, 28].  Briefly, the intestinal section was minced in 
oxygenated Tyrodes buffer (Sigma), washed 3 times to remove feces and incubated for 20 min at 
37ºC in freshly oxygenated Tyrodes buffer.  The supernatant was collected and stored at -80ºC 
until assayed for PGE2 by EIA (Cayman Chemicals).  The PGE2 concentration was normalized 
to total intestinal protein which was determined by BCA analysis and expressed as pg PGE2 per 
mg protein.   
2.7 Cox-2 mRNA Expression 
Mid-jejunal intestinal sections were snap-frozen in liquid nitrogen and stored at -80ºC 
until homogenized in Trizol (Invitrogen) and RNA extracted using the manufacturer’s protocol.  
RNA concentration was determined by spectrophotometry (nanodrop).  RNA (1 µg) was reverse-
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transcribed with a first strand cDNA synthesis kit (MBI Fermentas, Hanover, MD) with random 
hexamer primers.  The cDNA was subjected to real-time PCR on a mini-Opticon thermocycler 
(Bio-Rad).  PCR was performed using SYBR green in 25 l volumes with the following 
amplification conditions: 95°C for 3 min followed by 50 cycles of 95°C for 10 sec, 58°C for 30 
sec and 72°C for 10 sec.  All reactions were performed in duplicate.  After normalization to 18s 
rRNA, relative gene expression between treatment groups was determined using the comparative 
Ct method.  18s rRNA was selected as the internal standard based on preliminary studies 
indicating no significant differences in the 18s rRNA quantities between treatment groups.  The 
fold change in Cox-2 mRNA was determined relative to the Cox-2 mRNA level of the C57Bl/6 
(wild-type) Sham-treated control group after normalization. .  Cox-2 primers were: sense, 5`-
ATCCTGCCAGCTCCACCG- 3’; anti-sense, 5`-TGGTCAAATCCTGTGCTC ATACAT -3’ 
and 18s primers were: sense, 5`-GGTTGATCCTGCCAGTAGC- 3’; anti-sense, 5`-
GCGACCAAAGGAACCATAAC -3’.  Primer sequences were designed by Beacon Designer 
5.0 (Premier Software, Palo Alto, CA) and synthesized by Integrated DNA Technologies 
(Coralville, IA).   
2.8 Antibody Purification 
Protein L bead columns (Pierce) were used to purify all antibody isotypes of 
Immunoglobulins (Ig) from C57Bl/6 sera. Multiplex analysis indicated that IgM, IgG1, IgG2b 
and IgG3 were present in similar proportions to those found in the sera (data not shown).  Beads 
were packed into a 0.5 ml bead bed and 0.5 ml sera applied to each column.  Multiple Ig 
fractions were collected and each analyzed by spectrophotometer.  Those fractions containing the 
highest absorbance were pooled and dialyzed at 4oC overnight in phosphate buffered saline 
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(PBS).  The PBS was changed twice during dialysis.  Dialyzed fractions were concentrated to 1 
mg per ml using Centriplus concentrators (Millipore).   
2.9 Statistical Analysis 
Statistical analysis was performed using an unpaired t-test or one-way ANOVA with 
Newman-Keuls post hoc analysis (Graphpad Prism 4).  Data were expressed as the mean ± SEM 
analyses.  Data were deemed to be statistically different when p < 0.05. 
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3.  Results 
3.1 Lipidomic analysis of the molecular composition of intestinal phospholipids, sphingomyelin, 
and free arachidonic acid in Sham-treated wild-type mice 
Using ESI-MS/MS, characterization of the jejunal polar glycerophospholipids, 
sphingomyelin, and free arachidonic acid (AA) of Sham-treated wild-type (C57Bl/6) mice 
revealed that phosphatidylcholines, including diacyl (PC), acyl,alk(en)yl (ePC), and monoacyl 
(lysoPC) species, and phosphatidylethanolamines, including diacyl (PE), acyl,alk(en)yl (ePE), 
and monoacyl (lysoPE) classes, are the major phospholipids of the jejunum making up 56 mol% 
and 18 mol% respectively of the classes analyzed in C57Bl/6 wild-type mice (Fig. 1A).  
Phosphatidylinositol (PI), sphingomyelin (SM), and phosphatidylserine (PS) represented 8, 10, 
and 6 mol% respectively, while phosphatidic acid (PA), phosphatidylglycerol (PG), monoacyl 
PG (lysoPG) and free AA were present in lesser amounts (Fig. 1A).  
The fatty acyl compositions of the various jejunal phospholipid classes were different 
(Fig. 1B).  In the PC class, species containing a total of 34 and 36 fatty acyl carbons were most 
abundant, while PE and PS species containing 36, 38, and 40 carbons were most abundant.  The 
38:4 species of PI represented nearly half (45%) of the total PI.  Mass spectral product ion 
analysis indicated that each of the major diacylphospholipid classes included molecular species 
containing AA, which is also known as 20:4.  For example, 36:4 PC and 38:4 PC were primarily 
16:0-20:4 and 18:0-20:4 PC, 38:4 PE was primarily 18:0-20:4 PE, 38:4 PS was primarily 18:0-
20:4 PS, and 38:4 PI was primarily 18:0-20:4 PI (Fig. 1B). 
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3.2 Following IR, Rag-1-/- mice sustain significantly decreased damage compared to wild-type 
mice 
Rag-1-/- mice sustain significantly less IR-induced mesenteric injury than C57Bl/6 wild-
type mice at 2 h post ischemia [15].  To verify this finding and examine the extent of injury at 
earlier time points of reperfusion, Rag-1-/- mice and wild-type mice were subjected to 30 min 
ischemia followed by 15, 30 or 120 min reperfusion.  As indicated in Figure 2A, intestinal 
damage in Rag-1-/- mice was significantly attenuated compared to wild-type mice at all observed 
time points.  Sham treatment of either mouse strain resulted in no damage as indicated by the low 
injury scores (Fig. 2A).  Wild-type mice sustained significant damage compared to the Sham-
treated mice by 15 min reperfusion (Fig. 2A, B).  The damage increased slightly by 2 h post 
ischemia (Fig. 2A, C).  In contrast, Rag-1-/- mice sustained minimal damage at all time points 
measured (Fig. 2A, D, E).  Administration of wild-type Ab to Rag-1-/- mice results in 
significantly increased intestinal damage by 15 min post ischemia (Fig. 2A).  The data indicate 
that antibody-mediated intestinal damage occurs within 15 min after reperfusion begins in wild-
type mice.  The damage was further increased by 2 h post ischemia (Fig. 2A, F). 
 
3.3 In response to IR, palmitoyl and stearoyl lysoPCs and free arachidonic acid levels are 
significantly increased in intestines  
Mass spectrometry analysis allows identification of individual lipid molecular species.  
The data suggest that lysoPC and lysoPE rise quickly after IR, with lysoPC becoming 
significantly higher in the IR group than in the Sham group at 30 min of reperfusion after 
ischemia (Fig. 3A).  LysoPG also rose over time with significant increases in the IR group 
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compared to the Sham group at 30 and 120 min post-ischemia (Fig. 3A).  PC levels decreased 
upon reperfusion, with significant differences in the IR compared to the Sham group at 30 and 
120 min reperfusion (Fig. 3B).  Neither PE nor lysoPE were significantly altered during 
reperfusion (Fig. 3A, B).  The levels of lysoPC were maximal at 30 min after IR with 5.8 ± 0.43 
(SEM) mol% compared to 2.6 ± 0.53 (SEM) mol% following Sham treatment.  Figure 4 shows 
that five major lysoPC molecular species, 16:0, 18:2, 18:1, 18:0 and 20:4, increased following 
IR, with palmitoyl (16:0) and stearoyl (18:0) lysoPCs the most prominent.  Free AA levels were 
increased by IR treatment at 15 min post ischemia (Fig. 3C and 4A).  By 30 min reperfusion, free 
AA levels in Sham-treated wild-type mice were 1.5 mol%, while free AA levels of IR- treated 
wild-type mice were 4.6 mol%.  The elevated free AA was maintained at 120 min post ischemia.  
Taken together, the data suggest that activation of acyl hydrolytic activity during or following IR 
results in hydrolysis of phospholipids to lysolipids and free fatty acids, in particular free AA. 
3.4 Jejunal lipid composition is similar between Rag-1 -/- mice and wild-type mice during 
mesenteric reperfusion 
Rag-1-/- mice are naturally resistant to IR-induced damage.  Examination of total jejunal 
lipid amounts between mouse strains revealed no significant differences (Table 1).  Additionally, 
comparison of intestinal lipid class composition of Sham-treated mice (Table 2) showed no 
significant differences between wild-type and Rag-1-/- mice.  Acyl composition within classes 
was also similar between wild-type and Rag-1-/- Sham-treated mice (Table 3).  Because Rag-1-/- 
mice sustain less IR-induced intestinal damage as compared to wild-type mice, we tested the 
hypothesis that changes in lipid composition in response to IR would differ between strains.  
Results indicated that total lipid amount and composition from mid-jejunal samples collected at 
15, 30 and 120 min post ischemia did not display differences between the strains of mice at any 
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time of reperfusion examined (Table 1 and Fig. 5).  The major change occurring in response to 
IR in the measured phospholipids of the Rag-1-/- mice, as in the wild-type mice, was the 
production of lysoPC species (Fig. 5).  As in wild-type (C57Bl/6) mice, free AA levels increased 
in response to IR in the Rag-1-/- mice (Fig. 5), with Rag-1-/- free AA levels at 120 min after 
reperfusion at 1.5 mol% in Sham-treated and 4.5 mol% in the IR group. 
3.5 IR-induced Cox-2 mediated prostaglandin E2 expression requires antibody 
The formation of PGE2 requires multiple enzymatic activities, including an acyl 
hydrolase, phospholipase A2 (PLA2) which releases free AA.  Subsequently, cyclooxygenase 
converts free AA to PGH2, which in turn is converted to PGE2.  Previous studies have correlated 
IR-induced inflammation and tissue damage with increased PGE2 production in wild-type mice 
after 2 h reperfusion [4, 12, 28].  Previous studies, using inhibitors of Cox-2, demonstrated that 
PGE2 is required for IR-induced inflammation and tissue damage in wild-type mice after 2 h 
reperfusion [29].  Therefore, we quantified intestinal PGE2 production in wild-type and Rag-1
-/- 
mice at 2 h post ischemia.  As in previous studies, we observed that wild-type IR treated mice 
had significantly increased PGE2 concentrations compared to the Sham treatment group (Fig. 
6A).  In contrast, PGE2 concentrations were not significantly increased in response to IR in Rag-
1-/- mice.  Administration of wild-type Ab prior to intestinal IR induced significant 
concentrations of intestinal PGE2 in Rag-1
-/- mice within 120 min post ischemia.  The observed 
difference in PGE2 production, despite similar levels of free AA, in wild-type and antibody-
deficient mice, suggest that Ab are required for IR-induced PGE2 production from AA.   
To better understand the Ab requirement, we compared the IR-induced expression of 
Cox-2 mRNA in wild-type and Rag-1-/- mice.  Cox-2 expression was rapidly increased in 
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response to IR in wild-type mice (Fig. 6B) and the elevated expression was maintained for 2 h 
post ischemia.  In contrast, Cox-2 expression was not elevated at any time point in similarly 
treated Rag-1-/- mice (Fig. 6B).  Importantly, Cox2 mRNA expression increased in Rag-1-/- mice 
which were pretreated with Ab purified from wild-type mice.  These data suggest that Ab have a 
role in Cox-2 activation. 
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4.  Discussion 
Using ESI-MS/MS, we determined the phospholipid profile of the mid-jejunum of Sham- 
and IR-treated mice.  We showed that IR induces an increase in intestinal lysoPC and free AA in 
wild-type and Rag-1-/- mice.  Despite this increase in both strains of mice, Rag-1-/- mice did not 
exhibit Cox-2 mediated PGE2 production and intestinal damage as did wild-type mice.  These 
data indicate that the production of lysoPC and free AA occurs early in the IR-induced process of 
cellular injury.  In addition, Ab present in wild-type mice and lacking in Rag-1-/- mice are 
required for Cox-2-mediated PGE2 production but not for the IR-induced intestinal lipid 
alterations.   
Phosphatidylcholine, PI, PS, PE and SM were the main lipid classes present in both wild-
type and Rag-1-/- mice after Sham treatment (Fig. 1 and Table 2).  Similar results were obtained 
by ESI-MS/MS analysis of untreated mouse and rat intestines [16, 30].  Hicks et al found the 
16:0-18:2 was a prominent PC species in rat intestine [16].  These data are consistent with the 
current data, which indicate the most prominent PC species was 34:2 (Fig. 1).  A recent study by 
Braun et al also showed that normal mouse jejunum expressed a 496 Da and 524 Da lysoPC in 
the highest concentrations [18].  These masses correlate with the [M + H]+ adducts of the 
predominant 16:0 and 18:0 lysoPC species in Sham-treated animals (Fig.4).  This is consistent 
with formation of lysoPCs by a lipase acting at the sn2 position since mammalian lipids typically 
are enriched in saturated fatty acids at the 1-position and polyunsaturated fatty acids at the 2-
position.   
Previously, there has been limited use of ESI-MS/MS to study lipids in intestinal disease 
with variable results depending on the disease model.  Glycerophospholipids were not 
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significantly changed in response to 15 Gy of total body irradiation [30].  However, using 
MS/MS, Ehehalt et al found that the intestinal mucus of ulcerative colitis patients contained 
significantly less of the protective glycerophospholipids PC and lysoPC with no significant 
differences in the molecular species between diseased and normal subjects [17].  Similarly, 
Braun et al recently showed that PC levels were significantly lower than normal in ulcerative 
colitis patients but not in patients with Crohn’s disease [18].  Correlating with this finding, the 
lysoPC to PC ratio also increased [18].  The present study showed that IR increased lysoPC with 
a concomitant decrease in PC (Fig. 3A, B).  Others have found that PLA2 activity and the 
subsequent lysoPC:PC ratio increased in response to IR, although these studies involved 2 h 
ischemia and 5 min reperfusion [31].  In addition, we found the lysoPC increase was specifically 
in the 16 and 18 carbon molecular species (Fig. 4).  Lysophosphosphatidylcholine tends to form 
non-bilayer (micelle) structures and can destabilize lipid bilayers. [32].   Specifically, during 
intestinal IR lysoPC contributes to intestinal permeability [33].  In addition to increased lysoPC 
levels following IR treatment, we found increased intestinal free AA levels.  Similar significantly 
increased free AA levels occurred in the inflamed intestinal mucosa of patients with Crohn’s 
disease when compared to non-inflamed mucosa [35].  Thus, some, but not all, forms of 
intestinal damage alter the lipid profile by changing either the lipid classes or molecular species.   
It appears as though Ab are essential for the release of PGE2 and that PGE2 production 
contributes to IR-induced damage.  Cox-2 mediated PGE2 production has been correlated with 
IR-induced damage via use of selective Cox-2 or PLA2 inhibitors [29, 36, 37].  Previous studies 
also indicate that treatment of complement receptor 1 and 2 deficient mice with anti-
phospholipid Ab induces damage and eicosanoid production similar to that of wild-type mice 
[15], further supporting the role of Ab involvement in cellular damage.  The specific role of Ab 
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in PGE2 production is currently unknown.  Early studies showed that intestinal smooth muscle 
cells release PGE2 in response to IL-1 and LPS [38].  In addition, recent studies indicate that, in 
the absence of the LPS receptor, TLR4 significantly attenuated intestinal damage and Cox-2 
expression [29].  It is possible that Ab recognize a lipid moiety expressed on the cell surface or 
bound to a surface receptor, triggering Cox-2 expression which leads to formation of PGE2 (Fig. 
6).   
Although Ab appear important for Cox-2 catalyzed formation of PGE2, Ab are not 
required for cleavage of PC to lysoPC.  This is indicated by the fact that after IR, Rag-1-/- mice 
express quantities of lysoPC similar to those of wild-type mice without elevated PGE2 and 
subsequent tissue damage.  The specific phospholipase which produces lysoPC in the intestines 
during IR is currently unknown.  Previous studies demonstrate a role for PLA2 and subsequent 
AA formation in glomerular epithelial cell damage due to the complement complex C5b-9 [39].  
In vitro studies also indicate that calcium independent PLA2 induces damage in cardiomyocytes 
following simulated IR [40, 41].  The contribution of soluble PLA2 (sPLA2) is controversial.  
Inhibitory studies suggested that sPLA2 is critical in intestinal IR induced lung damage at 2-8 h 
post reperfusion [42, 43] and may play a role in intestinal damage at 3 h post reperfusion [37].  
Our data indicate that lysoPC 16:0 and lysoPC 18:0 are rapidly increased in the intestine in 
response to IR and previous studies indicated that these lipids uncompetitively inhibit sPLA2 
expression [33].  It is possible that multiple PLA2s are responsible for cleavage of PC to lysoPC.   
In summary, using ESI-MS/MS, we have shown that wild-type C57Bl/6 and antibody-
deficient Rag-1-/- mice have conserved lipid profiles.  In response to intestinal IR, both strains of 
mice show increased levels of lysoPC.  However, Rag-1-/- mice produced significantly less Cox-
2 mediated PGE2 compared to wild-type mice.  With the injection of wild-type antibodies into 
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Rag-1-/- mice, Cox-2 mRNA expression and PGE2 concentrations were restored to levels similar 
to those observed in wild-type mice.  Thus, antibodies play a role in inducing intestinal damage. 
Identification of the specific lipid antigens may provide improved therapeutics for the prevention 
of tissue damage associated with ischemia. 
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Figure Legends 
 
Figure 1: ESI-MS/MS identifies mid-jejunal lipids in Sham-treated C57Bl/6 mice 
Lipids were extracted from mid-jejunal sections from Sham-treated C57Bl/6 mice and analyzed 
by ESI-MS/MS to determine mol% of (A) polar jejunal glycerophospholipids, sphingomyelin 
and free arachidonic acid and (B) fatty acyl compositions of the major phospholipid classes.  
Each bar represents the mean ± SEM of 10 mice. 
 
Figure 2: Rag-1-/- mice sustain significantly less IR-induced intestinal damage than wild-
type mice 
Rag-1-/- (open bars) and C57Bl/6 (solid bars) mice were subjected to mesenteric IR with 15, 30 
or 120 min reperfusion or Sham treatment.  Additional Rag-1-/- mice received 100 g purified 
C57Bl/6 antibody prior to IR with 120 min reperfusion (striped bar).  Formalin fixed, H & E 
stained intestinal sections were scored for mucosal injury as described in Materials and Methods.  
Average injury scores ± SEM for each treatment group of 4 to 10 mice are shown (A).  
Representative sections of intestinal tissue after 15 min reperfusion (B, D) or 120 min 
reperfusion (C, E) from Rag-1-/- mice (D, E) or C57Bl/6 mice (B, C) are shown.  Also shown is a 
representative section of intestinal tissue at 120 min reperfusion from Rag-1-/- mice receiving 
wild-type Ab prior to IR treatment (F).  A one-way ANOVA with Newman-Keuls post-hoc test 
was used to determine significance; * indicates significant difference (p < 0.05) from Sham 
treatment and τ indicates significant difference from wild-type.   
 29 
 
Figure 3: IR induces a rapid increase in intestinal lysolipids and free arachidonic acid with 
a concurrent decrease in phospholipid  
Mid-jejunal lipid extracts from IR treated C57Bl/6 mice were analyzed by ESI-MS/MS.  Mol% 
lysoPC, lysoPE and lysoPG (A), PC and PE (B) and free arachidonic acid (C) were examined at 
0 (Sham treatment), 15, 30 and 120 min post ischemia.  Mean ± SEM of 3 to 10 mice per group 
are shown.  One-way ANOVA with Newman-Keuls post-hoc test was used to determine 
significance; * indicates significance from Sham treatment where p < 0.05. 
 
Figure 4: Specific lysoPC molecular species increase significantly within the intestine in 
response to IR 
C57Bl/6 mice were subjected to Sham (open bars) or IR (solid bars) with 15 (A) 30 (B) or 120 
(C) min reperfusion prior to ESI-MS/MS determination of mol% of lipid analyzed within the 
intestine.  The major lysoPC species which increased in response to IR, lysoPC 16:0, 18:2, 18:1, 
18:0, and 20:4 are illustrated.  Each bar represents the mean ± SEM with 5-10 mice per group.  
An unpaired t-test determined significant difference (p < 0.05) between Sham and IR treatment 
within a molecular species (*) and one way ANOVA with Newman-Keuls post hoc analysis was 
used to determine significance of a species over time (θ) where p < 0.05. 
 
Figure 5: Intestinal lipid composition is conserved between C57Bl/6 and Rag-1-/- mice 
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C57Bl/6 (solid bars) and Rag-1-/- (open bars) mice were subjected to IR treatment with 15, 30 or 
120 min reperfusion prior to collection of the mid-jejunum.  After intestinal lipid extraction, ESI-
MS/MS analysis determined mol% lipid analyzed from the mid-jejunum of each animal.  Each 
bar represents the mean ± SEM with 4 to 5 mice per group.  None of the values are significantly 
different than the others  at p < 0.05. 
Figure 6: Antibody is required for IR-induced Cox-2 mediated PGE2 expression  
C57Bl/6 (solid bars) or Rag-1-/- mice (open bars) or Rag-1-/- mice treated with 100 g purified Ab 
(striped bars) were subjected to Sham or IR treatment prior to collection of mid-jejunal tissue at 
15, 30 or 120 min post ischemia.  A. Ex vivo intestinal PGE2 production was determined by 
enzyme immunoassays.  Each bar represents the average ± SEM with 5 to 9 animals per group.  
B. RT-PCR determined intestinal Cox-2 expression from additional intestinal sections.  The fold 
change was determined by the Ct method after normalization to 18s rRNA.  Each bar represents 
the average ± SEM with 4 to 8 animals per group.  One-way ANOVA with Newman-Keuls post-
hoc test was used to determine significance; (*) indicates p < 0.05 compared to Sham treatment. 
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Table 1. Total jejunal lipids analyzed in Sham and IR treated C57Bl/6 and Rag-1-/- mice. 
  
 
 
 
 
 
 
1 Each value is the nmol total lipids per mg tissue analyzed and is a mean of 4 to 8 mice per time 
point.  None of the values are significantly different than the others. 
 
Total lipid  
nmol/mg protein 
(mean ± SEM)1 
Sham IR 15 IR 30 IR 120 
B6 241 ± 85 133 ± 13 105 ± 23 152 ± 36 
Rag 110 ± 13 81 ± 17 94 ± 14 129 ± 4 
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Table 2.  C57Bl/6 and Rag-1-/- mice have similar intestinal lipid class compositions.  
Lipid class1 B6 (mol% ± SEM)2 Rag (mol% ± SEM) 2 
Lyso PC 2.65 ± 0.53 2.20 ± 035 
PC 52.92 ± 0.72 51.90 ± 0.80 
ePC 2.50 ± 0.09 2.48 ± 0.09 
SM 7.8 ± 0.43 7.98 ± 0.23 
Lyso PE 0.34 ± 0.04 0.25 ± 0.04 
PE 18.16 ± 0.52 17.69 ± 0.29 
ePE 3.27 ± 0.21 3.65 ± 0.27 
PI 5.2 ± 0.19 6.00 ± 0.30 
PS 4.45 ± 0.42 4.22 ± 0.40 
PA 0.70 ± 0.12 0.60 ± 0.10 
Lyso PG 0.01 ± 0.00 0.02 ± 0.00 
PG 1.36 ± 0.13 1.40 ± 0.16 
Free AA 1.50 ± 0.13 1.46 ± 0.22 
 
1Lipids were extracted from mid-jejunal intestinal sections from C57Bl/6 (B6) and Rag-1-/- (Rag) 
Sham-treated mice.  ESI-MS/MS analysis determined mol% of polar intestinal 
glycerophospholipids, sphingomyelin, and free arachidonic acid.   
2The mean ± SEM of 5 to 9 mice.  
 
Table 3. C57B1/6 and Rag-1-/- mice maintain similar intestinal acyl chains within the lipid classes1.  
 PC PE PI PS 
Acyl chains2 B63 Rag3 B6 Rag B6 Rag B6 Rag 
32:0 1.22 ± 0.05 1.20 ± 0.03 0.01 ± 0.00 0.01 ± 0.00 ND4 ND 0.00 ± 0.00 0.00 ± 0.00 
34:2 15.32 ± 0.96 13.97 ± 0.78 0.88 ± 0.06 0.76 ± 0.06 0.42 ± 0.02 0.49 ± 0.04 0.03 ± 0.00 0.02 ± 0.00 
34:1 2.39 ± 0.22 2.18 ± 0.15 0.18 ± 0.01 0.16 ± 0.01 0.13 ± 0.01 0.17 ± 0.02 0.03 ± 0.00 0.02 ± 0.00 
34:0 0.27 ± 0.02 0.25 ± 0.02 0.01 ± 0.00 0.01 ± 0.00 ND ND 0.01 ± 0.00 0.01 ± 0.00 
36:5 0.99 ± 0.08 1.00 ± 0.07 0.15 ± 0.01 0.13 ± 0.01 0.04 ± 0.00 0.06 ± 0.01 0.00 ± 0.00 0.00 ± 0.00 
36:4 5.05 ± 0.16 5.26 ± 0.11 0.64 ± 0.02 0.60 ± 0.01 0.49 ± 0.04 0.62 ± 0.04 0.01 ± 0.00 0.01 ± 0.00 
36:3 3.63 ± 0.11 3.50 ± 0.08 0.83 ± 0.03 0.72 ± 0.03 0.23 ± 0.01 0.26 ± 0.02 0.05 ± 0.01 0.05 ± 0.01 
36:2 11.92 ± 0.34 12.86 ± 0.50 4.46 ± 0.22 4.17 ± 0.18 0.67 ± 0.03 0.70 ± 0.04 1.31  ± 0.10 1.29 ± 0.10 
36:1 0.94 ± 0.08 0.94 ± 0.08 0.41 ± 0.02 0.44 ± 0.01 0.07 ± 0.00 0.07 ± 0.00 0.54  ± 0.07 0.51 ± 0.08 
38:6 1.48 ± 0.05 1.48 ± 0.03 0.96 ± 0.03 0.87 ± 0.02 0.09 ± 0.01 0.10 ± 0.01 0.01 ± 0.00 0.01 ± 0.00 
38:5 1.52 ± 0.05 1.69 ± 0.03 1.06 ± 0.04 1.09 ± 0.04 0.28 ± 0.01 0.32 ± 0.02 0.05 ± 0.00 0.06 ± 0.00 
38:4 2.94 ± 0.09 3.27 ± 0.09 3.71 ± 0.11 3.95 ± 0.10 2.36 ± 0.08 2.69 ± 0.12 0.44 ± 0.04 0.47 ± 0.04 
38:3 0.72 ± 0.04 0.77 ± 0.04 0.49 ± 0.04 0.49 ± 0.03 0.25 ± 0.01 0.28 ± 0.02 0.31 ± 0.04 0.28 ± 0.04 
40:7 0.25 ± 0.01 0.24 ± 0.02 0.58 ± 0.02 0.52 ± 0.01 0.01 ± 0.00 0.00 ± 0.00 0.02 ± 0.00 0.02 ± 0.00 
40:6 0.98 ± 0.05 1.03 ± 0.05 2.35 ± 0.12 2.27 ± 0.07 0.14 ± 0.01 0.14 ± 0.01 0.95 ± 0.11 0.84 ± 0.09 
40:5  0.18 ± 0.01   0.20 ± 0.01 0.34 ± 0.02 0.33 ±  0.01 0.04 ± 0.00 0.05 ± 0.00 0.21 ± 0.02 0.19 ± 0.01 
1.Lipids were extracted from mid-jejunal intestinal sections from C57B1/6 (B6) and Rag-1-/- (Rag) Sham treated mice.  ESI-
MS/MS analysis determined mol% of the fatty acid chains for the major lipid classes.   
2  Total acyl carbons : total double bonds 
3The mol% mean ± SEM of 5 to 9 mice. 
4 Not determined 
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